555 related articles for article (PubMed ID: 22367042)
41. Intermediate-Term and Long-Term Outcomes With the Boston Type 1 Keratoprosthesis in Aniridia.
Shah KJ; Cheung AY; Holland EJ
Cornea; 2018 Jan; 37(1):11-14. PubMed ID: 28990998
[TBL] [Abstract][Full Text] [Related]
42. Outcomes of the Boston Type I Keratoprosthesis as the Primary Penetrating Corneal Procedure.
Driver TH; Aravena C; Duong HNV; Christenbury JG; Yu F; Basak SK; Aldave AJ
Cornea; 2018 Nov; 37(11):1400-1407. PubMed ID: 30157053
[TBL] [Abstract][Full Text] [Related]
43. Pediatric keratoprosthesis.
Aquavella JV; Gearinger MD; Akpek EK; McCormick GJ
Ophthalmology; 2007 May; 114(5):989-94. PubMed ID: 17467531
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of a low-cost design keratoprosthesis in end-stage corneal disease: a preliminary study.
Sharma N; Falera R; Arora T; Agarwal T; Bandivadekar P; Vajpayee RB
Br J Ophthalmol; 2016 Mar; 100(3):323-7. PubMed ID: 26271267
[TBL] [Abstract][Full Text] [Related]
45. Boston type 1 keratoprosthesis for failed keratoplasty.
Hager JL; Phillips DL; Goins KM; Kitzmann AS; Greiner MA; Cohen AW; Welder JD; Wagoner MD
Int Ophthalmol; 2016 Feb; 36(1):73-78. PubMed ID: 25975459
[TBL] [Abstract][Full Text] [Related]
46. Visual improvement after cultivated oral mucosal epithelial transplantation.
Sotozono C; Inatomi T; Nakamura T; Koizumi N; Yokoi N; Ueta M; Matsuyama K; Miyakoda K; Kaneda H; Fukushima M; Kinoshita S
Ophthalmology; 2013 Jan; 120(1):193-200. PubMed ID: 23084239
[TBL] [Abstract][Full Text] [Related]
47. The Boston keratoprosthesis type I in mucous membrane pemphigoid.
Palioura S; Kim B; Dohlman CH; Chodosh J
Cornea; 2013 Jul; 32(7):956-61. PubMed ID: 23538625
[TBL] [Abstract][Full Text] [Related]
48. Large-diameter penetrating keratoplasty: indications and outcomes.
Skeens HM; Holland EJ
Cornea; 2010 Mar; 29(3):296-301. PubMed ID: 20118782
[TBL] [Abstract][Full Text] [Related]
49. Long-term outcomes of the MICOF keratoprosthesis surgery.
Wang L; He X; Wang Q; Wu T; Liu A; Huang Y
Ocul Surf; 2021 Jul; 21():178-185. PubMed ID: 34118425
[TBL] [Abstract][Full Text] [Related]
50. Infectious keratitis after Boston type 1 keratoprosthesis implantation.
Chan CC; Holland EJ
Cornea; 2012 Oct; 31(10):1128-34. PubMed ID: 22960647
[TBL] [Abstract][Full Text] [Related]
51. AlphaCor keratoprosthesis: postoperative development of six patients.
Holak SA; Holak HM; Bleckmann H
Graefes Arch Clin Exp Ophthalmol; 2009 Apr; 247(4):535-9. PubMed ID: 18941767
[TBL] [Abstract][Full Text] [Related]
52. Treatment of aniridia with Boston type I keratoprosthesis.
Rixen JJ; Cohen AW; Kitzmann AS; Wagoner MD; Goins KM
Cornea; 2013 Jul; 32(7):947-50. PubMed ID: 23449480
[TBL] [Abstract][Full Text] [Related]
53. Long-term outcomes of boston type 1 keratoprosthesis implantation: a retrospective multicenter cohort.
Srikumaran D; Munoz B; Aldave AJ; Aquavella JV; Hannush SB; Schultze R; Belin M; Akpek EK
Ophthalmology; 2014 Nov; 121(11):2159-64. PubMed ID: 25017414
[TBL] [Abstract][Full Text] [Related]
54. Long-term visual outcomes of the Boston type I keratoprosthesis in Canada.
Szigiato AA; Bostan C; Nayman T; Harissi-Dagher M
Br J Ophthalmol; 2020 Nov; 104(11):1601-1607. PubMed ID: 32066560
[TBL] [Abstract][Full Text] [Related]
55. Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.
Goins KM; Kitzmann AS; Greiner MA; Kwon YH; Alward WL; Ledolter J; Wagoner MD
Cornea; 2016 Sep; 35(9):1165-74. PubMed ID: 27191675
[TBL] [Abstract][Full Text] [Related]
56. AlphaCor keratoprosthesis: a novel approach to minimize the risks of long-term postoperative complications.
Ngakeng V; Hauck MJ; Price MO; Price FW
Cornea; 2008 Sep; 27(8):905-10. PubMed ID: 18724152
[TBL] [Abstract][Full Text] [Related]
57. Infectious endophthalmitis in adult eyes receiving Boston type I keratoprosthesis.
Ramchandran RS; Diloreto DA; Chung MM; Kleinman DM; Plotnik RP; Graman P; Aquavella JV
Ophthalmology; 2012 Apr; 119(4):674-81. PubMed ID: 22266108
[TBL] [Abstract][Full Text] [Related]
58. Boston keratoprosthesis outcomes and complications.
Chew HF; Ayres BD; Hammersmith KM; Rapuano CJ; Laibson PR; Myers JS; Jin YP; Cohen EJ
Cornea; 2009 Oct; 28(9):989-96. PubMed ID: 19724214
[TBL] [Abstract][Full Text] [Related]
59. Long-Term Outcomes of the Boston Type I Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency.
Aravena C; Bozkurt TK; Yu F; Aldave AJ
Cornea; 2016 Sep; 35(9):1156-64. PubMed ID: 27387566
[TBL] [Abstract][Full Text] [Related]
60. Long-term visual acuity, retention and complications observed with the type-I and type-II Boston keratoprostheses in an Irish population.
Duignan ES; Ní Dhubhghaill S; Malone C; Power W
Br J Ophthalmol; 2016 Aug; 100(8):1093-7. PubMed ID: 26628625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
